Replies to post #34221 on Intellipharmaceutics International Inc. (IPCI)

[stocking4ms]

Meeting/voting points:
1. to receive the audited consolidated financial statements of the Company for the financial year ended November 30, 2017, and the
auditor’s report thereon;
2. to elect six (6) directors;
3. to reappoint the auditor and to authorize the directors to fix the auditor’s remuneration;
4. to pass a resolution to approve all unallocated options, rights and entitlements under the Company’s stock option plan;
5. to approve the two year extension of the performance-based stock options granted to certain directors and officers as more
particularly described in the management information circular prepared for the Meeting (the “Management Proxy Circular”); and
6. to transact such further and other business as may properly come before the Meeting or any adjournments thereof.